Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-29

Utility of tumor antigens as therapeutic and diagnostic tools

Objectif

The serological profiling of anti-tumour associated antigen responses through large- scale efforts has identified over 2000 antigens. Our preliminary results show a correlation between antibody responses against a number of these with parameters indicative of indolent disease and with longer overall survival in lung cancer patients. The first aim of this project is to extend and establish these observations. Since these are antigens primarily expressed by tissues of neuroectodermal origin, we want to prove the absence of an association of antibodies against them and autoimmune paraneoplastic neuronal degeneration.

Champ scientifique (EuroSciVoc)

Thème(s)

Appel à propositions

FP6-2004-MOBILITY-12
Voir d’autres projets de cet appel

Régime de financement

EIF - Marie Curie actions-Intra-European Fellowships

Coordinateur

BILKENT UNIVERSITESI
Contribution de l’UE
Aucune donnée
Coût total
Aucune donnée